Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells based on their genetics. Its technology targets solid tumors based… Read More
Microsoft and Seattle-based Adaptive Biotechnologies announced Friday they will work together to map the immune response to COVID-19. The goal of the partnership is to study population-wide immune responses to… Read More
Seattle biotech startup Silverback Therapeutics raised a $78.5 million investment round to support development of its therapies for cancer, fibrosis, and other conditions. Founded in 2016, Silverback’s ImmunoTAC technology can… Read More
Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new drug that fights aggressive breast cancers. Tucatinib is a daily… Read More
It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious diseases. After raising $143 million in an initial public offering… Read More
More than 100 biotech researchers, industry executives and government officials met at the White House today for a summit focusing on America’s bioeconomy — the range of products, services and… Read More
NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance of stem cells in drug development. With the acquisition, NanoSurface… Read More
As it closes in on one of the most valuable land deals in Seattle history, Alexandria Real Estate Equities is betting that biotech can thrive in a real estate market… Read More
Bluebird Bio is growing its nest in Seattle. The leading biotech company held a ribbon-cutting event Friday to celebrate the opening of its new cancer research facility where employees will… Read More
One of the last big chunks of land in the booming Seattle neighborhood of South Lake Union will turn into a life sciences hub — with proceeds of the sale… Read More
Story updated with comments from Scholz below. Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline of therapeutics that aim to kill cancer cells based on… Read More
Sujal Patel has seen a world-changing trend coming before. In 2001, in his mid-20s, he founded data storage technology company Isilon Systems in Seattle, correctly anticipating a massive increase in… Read More
Henrik Andersen, head of biologics development at Bristol-Myers Squibb, knows what it’s like to be at a hot biotech when it’s scooped up by a much larger player. Andersen was… Read More
The Fred Hutchinson Cancer Research Center has a historic new signpost on Seattle’s Lake Union. The institution has started adding its name on the Lake Union Steam Plant’s iconic smokestacks… Read More
Just Biotherapeutics, a Seattle-based company that aims to reduce the cost of protein drug development, announced an agreement Monday to be acquired by German biotech company Evotec for up to… Read More
Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has passed its first clinical trial with flying colors and is… Read More
Seattle biotech company Blaze Bioscience has raised $5 million in funding as it pursues a pivotal trial for its “Tumor Paint,” a molecule that binds to cancer cells and lights them… Read More
Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act only when needed, raised $11 million in an equity round, according to a new SEC… Read More
Big deals led to a banner year for U.S. digital health investments, which shot up 21 percent to $8.6 billion in 2018, according to a report from PwC and CB… Read More
For 30 years, scientists have been trying to unleash the promise of Interleukin-2 (IL-2), a powerful protein that fights cancer but is highly toxic. Researchers at the University of Washington… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition to the up-front payment, Adaptive could receive up to $2… Read More
Seattle-based biotech startup Immusoft this week closed a $20 million Series B venture capital round that will fuel development of its gene therapy technology. Founded in 2009, Immusoft develops immune cell… Read More
Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an agreement with drug giant Pfizer that includes $15 million in… Read More
CTI BioPharma announced Thursday that it will let go of half its employees in order to create more runway to develop its experimental drug Pacritinib, which treats the blood cancer… Read More
Rodeo Therapeutics, a Seattle-based biotech startup that is creating therapies to help the body regenerate tissue, has landed $3.7 million in venture funding, according to an SEC filing. The company… Read More
As a journalist, Luke Timmerman has covered biotech for more than 17 years. Now, the Timmerman Report founder is making headlines for his efforts to raise money for cancer research.… Read More
Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central nervous system disorders, such as migraines and Parkinson’s. This is… Read More
Seattle Genetics’ star cancer drug Adcetris has won Food and Drug Administration approval for treatment of a fast-growing type of non-Hodgkin lymphoma. The approval comes after the drug showed better… Read More
Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with the Securities and Exchange Commission. A representative of the Seattle-area… Read More
Life expectancy worldwide has more than doubled since the year 1900. Thanks to remarkable scientific breakthroughs, people today are living longer, healthier lives than any other point in history. But… Read More